Twist Bioscience Capital Expenditures (CapEx) Growth & History (TWST)

Twist Bioscience's capital expenditures (capex) was $28.0M for fiscal 2025.

View full Twist Bioscience company overview

Twist Bioscience annual capital expenditures (capex) history

Twist Bioscience annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20252025-09-30$28.0M$22.9M+451.69%
20242024-09-30$5.1M−$22.7M−81.73%
20232023-09-30$27.8M−$74.1M−72.73%
20222022-09-30$101.9M$74.8M+276.40%
20212021-09-30$27.1M$17.2M+174.23%
20202020-09-30$9.9M−$4.9M−33.13%
20192019-09-30$14.8M$11.1M+300.14%
20182018-09-30$3.7M−$2.9M−44.07%
20172017-09-30$6.6M

Twist Bioscience capital expenditures (capex) trends

Over the last five fiscal years, Twist Bioscience's capital expenditures (capex) increased from $9.9M to $28.0M, a change of $18.1M. The latest reported quarter, Q3 2026, shows $9.8M.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Twist Bioscience source filings ↗

Community posts

It’s quiet here.

No posts about TWST yet. Start the conversation.

Write the first post